Post hoc analyses of East Asian patients from the randomized placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer

Post hoc analyses of East Asian patients from the randomized placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer

10.1097/MD.0000000000007223

Saved in:
Bibliographic Details
Main Authors: Kim C.S., Choi Y.D., Lee S.E., Lee H.M., Ueda T., Yonese J., Fukagai T., Chiong E., Lau W., Abhyankar S., Theeuwes A., Tombal B., Beer T.M., Kimura G.
Other Authors: SURGERY
Format: Article
Published: Lippincott Williams and Wilkins 2018
Subjects:
antineoplastic agents
Asia
castration-resistant
disease-free survival
MDV 3100
prostatic neoplasms
Online Access:http://scholarbank.nus.edu.sg/handle/10635/146765
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Description
Summary:10.1097/MD.0000000000007223

Similar Items